356 related articles for article (PubMed ID: 29881672)
1. Recent developments in multimodality fluorescence imaging probes.
Zhao J; Chen J; Ma S; Liu Q; Huang L; Chen X; Lou K; Wang W
Acta Pharm Sin B; 2018 May; 8(3):320-338. PubMed ID: 29881672
[TBL] [Abstract][Full Text] [Related]
2.
Janasik D; Krawczyk T
Chemistry; 2022 Jan; 28(5):e202102556. PubMed ID: 34705306
[TBL] [Abstract][Full Text] [Related]
3. Multimodality imaging: beyond PET/CT and SPECT/CT.
Cherry SR
Semin Nucl Med; 2009 Sep; 39(5):348-53. PubMed ID: 19646559
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
5. Multimodality imaging of nanoparticle-based vaccines: Shedding light on immunology.
Younis MH; Tang Z; Cai W
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Sep; 14(5):e1807. PubMed ID: 35501142
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
7. Radioactive Nanomaterials for Multimodality Imaging.
Chen D; Dougherty CA; Yang D; Wu H; Hong H
Tomography; 2016 Mar; 2(1):3-16. PubMed ID: 27227167
[TBL] [Abstract][Full Text] [Related]
8. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
9. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
Culver J; Akers W; Achilefu S
J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Comparison of
Anttinen M; Ettala O; Malaspina S; Jambor I; Sandell M; Kajander S; Rinta-Kiikka I; Schildt J; Saukko E; Rautio P; Timonen KL; Matikainen T; Noponen T; Saunavaara J; Löyttyniemi E; Taimen P; Kemppainen J; Dean PB; Blanco Sequeiros R; Aronen HJ; Seppänen M; Boström PJ
Eur Urol Oncol; 2021 Aug; 4(4):635-644. PubMed ID: 32675047
[TBL] [Abstract][Full Text] [Related]
11. Tunable and noncytotoxic PET/SPECT-MRI multimodality imaging probes using colloidally stable ligand-free superparamagnetic iron oxide nanoparticles.
Pham TN; Lengkeek NA; Greguric I; Kim BJ; Pellegrini PA; Bickley SA; Tanudji MR; Jones SK; Hawkett BS; Pham BT
Int J Nanomedicine; 2017; 12():899-909. PubMed ID: 28184160
[TBL] [Abstract][Full Text] [Related]
12. Near-infrared fluorescent probes for imaging of amyloid plaques in Alzheimer׳s disease.
Tong H; Lou K; Wang W
Acta Pharm Sin B; 2015 Jan; 5(1):25-33. PubMed ID: 26579421
[TBL] [Abstract][Full Text] [Related]
13. Applications and software techniques for integrated cardiac multimodality imaging.
Slomka PJ; Berman DS; Germano G
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):27-41. PubMed ID: 18095905
[TBL] [Abstract][Full Text] [Related]
14. Future Challenges of Multimodality Imaging.
López-Mora DA; Lagos LA; Estorch M; Carrio I
Recent Results Cancer Res; 2020; 216():905-918. PubMed ID: 32594412
[TBL] [Abstract][Full Text] [Related]
15. PET-MR and SPECT-MR multimodality probes: Development and challenges.
Yang CT; Ghosh KK; Padmanabhan P; Langer O; Liu J; Eng DNC; Halldin C; Gulyás B
Theranostics; 2018; 8(22):6210-6232. PubMed ID: 30613293
[TBL] [Abstract][Full Text] [Related]
16. Multimodality imaging techniques.
Martí-Bonmatí L; Sopena R; Bartumeus P; Sopena P
Contrast Media Mol Imaging; 2010; 5(4):180-9. PubMed ID: 20812286
[TBL] [Abstract][Full Text] [Related]
17. Targeted PET/MRI Imaging Super Probes: A Critical Review of Opportunities and Challenges.
Kastelik-Hryniewiecka A; Jewula P; Bakalorz K; Kramer-Marek G; Kuźnik N
Int J Nanomedicine; 2021; 16():8465-8483. PubMed ID: 35002239
[TBL] [Abstract][Full Text] [Related]
18. Molecular and cellular imaging of the eye.
Nguyen VP; Zhe J; Hu J; Ahmed U; Paulus YM
Biomed Opt Express; 2024 Jan; 15(1):360-386. PubMed ID: 38223186
[TBL] [Abstract][Full Text] [Related]
19. Future challenges of multimodality imaging.
Estorch M; Carrio I
Recent Results Cancer Res; 2013; 187():403-15. PubMed ID: 23179890
[TBL] [Abstract][Full Text] [Related]
20. Molecular Imaging of Pancreatic Cancer with Antibodies.
England CG; Hernandez R; Eddine SB; Cai W
Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
